(Q57396337)
Statements
Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease (English)
0 references
March 2005
0 references
149
0 references
3
0 references
408-413
0 references